Pages that link to "Q30369059"

The following pages link to Aldosterone in salt-sensitive hypertension and metabolic syndrome. (Q30369059):

Displaying 31 items.

• Exercise induced adipokine changes and the metabolic syndrome (Q26822992) (← links)
• Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus (Q26829529) (← links)
• Reactive oxygen species and dopamine receptor function in essential hypertension (Q34971057) (← links)
• Analysis of metabolites in plasma reveals distinct metabolic features between Dahl salt-sensitive rats and consomic SS.13(BN) rats. (Q35581002) (← links)
• The metabolic syndrome and risk of chronic kidney disease: pathophysiology and intervention strategies (Q35864666) (← links)
• Obesity and renovascular disease (Q35958492) (← links)
• Exercise in the metabolic syndrome (Q36102382) (← links)
• Hypertension as part of the metabolic syndrome (Q37189315) (← links)
• The Association between Oxidative Stress and Metabolic Syndrome in Adults. (Q37376045) (← links)
• Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension (Q37418924) (← links)
• Aldosterone and arterial hypertension (Q37660912) (← links)
• Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy (Q37720499) (← links)
• Ambient tonicity and intestinal cytochrome CYP3A. (Q37725997) (← links)
• From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation (Q37786549) (← links)
• The Effect of Obesity on Chronic Kidney Disease (Q37825085) (← links)
• The metabolic syndrome and chronic kidney disease (Q39056509) (← links)
• Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways (Q39387327) (← links)
• Chronic antagonism of the mineralocorticoid receptor ameliorates hypertension and end organ damage in a rodent model of salt-sensitive hypertension (Q39635951) (← links)
• Modulation of adrenal aldosterone release by oxidative modification of low-density lipoprotein (Q39691253) (← links)
• VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production (Q40737068) (← links)
• The LRP1 Gene Polymorphism is associated with Increased Risk of Metabolic Syndrome Prevalence in the Serbian Population (Q41155887) (← links)
• Feedforward activation of endothelial ENaC by high sodium (Q42291112) (← links)
• Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats (Q43064232) (← links)
• Effect of high fat loading in Dahl salt-sensitive rats (Q43065467) (← links)
• Hindbrain mineralocorticoid mechanisms on sodium appetite. (Q45798876) (← links)
• Anti-obesity effects of Taif and Egyptian pomegranates: molecular study. (Q50456804) (← links)
• Genomic and rapid effects of aldosterone: what we know and do not know thus far. (Q51273122) (← links)
• The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study. (Q53685411) (← links)
• Plasma aldosterone is increased in class 2 and 3 obese essential hypertensive patients despite drug treatment (Q84059601) (← links)
• Mineralocorticoid Receptor Blockers: Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonists (Q89958005) (← links)
• Involvement of Vanin-1 in Ameliorating Effect of Oxidative Renal Tubular Injury in Dahl-Salt Sensitive Rats (Q90079402) (← links)